T Cell Receptor (TCR) T cell therapy, Chimeric Antigen Receptor (CAR) T cell therapy, CAR-macrophage cell therapy, and CAR-NK cell therapy are all provided by Creative Biolabs, which has established a number of advanced platforms with cutting-edge technologies and creative solutions with the goal of supporting the drug discovery and development of cellular and gene therapies through a consultation-based and strategic approach with great consideration given to scientific and regulatory issues. For more: https://www.creative-biolabs.com/immuno-oncology/chimeric-antigen-receptor-car-macrophage-cell-therapy.htm